I don't know how much knowledge you have of company valuation models, but the most sensitive variable is the growth rate g. Any small change in g has huge impacts on share price. FXL has much less prospects for growth due to them having legacy businesses, capital tied up in higher valued, low frequency BNPL products, pays a dividend etc. So slower growth means you can't compare FXL to rapidly growing (very high g ) companies like Afterpay.
Add to that the fact that FXL has high default rates and higher credit risk, and a less nimble business (although that side is comparable to ZipMoney)...
I'm sure FXL will do well, the whole sector is going through growth, but it's unlikely FXL will ever experience growth like APT and Z1P. AIMO.
- Forums
- ASX - By Stock
- HUM
- Buckle up for $2
Buckle up for $2, page-1440
-
- There are more pages in this discussion • 216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HUM (ASX) to my watchlist
|
|||||
Last
47.0¢ |
Change
0.020(4.44%) |
Mkt cap ! $230.9M |
Open | High | Low | Value | Volume |
45.0¢ | 47.0¢ | 45.0¢ | $203.3K | 443.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 24990 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 28966 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 24990 | 0.465 |
2 | 63000 | 0.460 |
2 | 74629 | 0.455 |
1 | 20001 | 0.450 |
1 | 44479 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 28966 | 4 |
0.475 | 14000 | 2 |
0.480 | 93369 | 3 |
0.485 | 20500 | 1 |
0.490 | 14039 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
HUM (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online